H. Baron et al., DOLICHOL-MEDIATED ENHANCED PROTEIN N-GLYCOSYLATION IN EXPERIMENTAL DIABETES - A POSSIBLE ADDITIONAL DELETERIOUS EFFECT OF HYPERGLYCEMIA, Journal of diabetes and its complications, 11(4), 1997, pp. 236-242
In liver cells from diabetic rats, an increased incorporation of label
led glucosamine into cellular and secretory proteins was found, when r
elated to the incorporation of labelled leucine. This increased N-glyc
osylation was present in the face of decreased synthesis of hepatic ce
llular and secretory proteins evident from reduced leucine incorporati
on and diminished glycosyltransferase activity. To elucidate the mecha
nisms involved we incubated isolated hepatocytes with two N-glycosylat
ion inhibitors: tunicamycin and 2-deoxyglucose. Tunicamycin exerted a
marked inhibitory effect on the incorporation rate of labelled glucosa
mine into proteins in liver cells from diabetic rats, while 2-deoxyglu
cose had a negligible effect on this process in these cells. These div
erse effects might be explained by the fact that tunicamycin acts thro
ugh strong association with the enzyme catalysing the first step in gl
ycoprotein synthesis, namely, the transfer of UDP-GlcNAc to dolichol-P
(indicating noncompetitive inhibition). This enzyme is reduced in liv
er cells from diabetic animals. On the other hand, 2-deoxyglucose exer
ts its effect by being attached to dolichol-P, preventing further elon
gation of oligosaccharide chain on the protein backbone. This latter e
ffect might be eliminated by excess dolichol-P (indicating competitive
inhibition). The dolichol content in liver extract from diabetic rats
was about 2.5-fold higher compared with nondiabetic rats (51.6 mu g/g
versus 20.6 mu g/g wet liver weight). These two lines of evidence con
firm the notion that the enhanced enzymatic glycosylation in liver fro
m diabetic animals is maintained by an increased hepatic dolichol conc
entration, which is most probably related to the hyperglycemia. Thus,
the dolishol-N-glycosylation pathway may represent another detrimental
aspect of hyperglycemia and may operate by dolichol mass action rathe
r than through glycosylating enzyme activity. (C) Elsevier Science Inc
., 1997.